9GIULIANI A,PIRRI G,NICOLOTTO S F.Antimicrbial peptides:an overvivew of a promising class of therapeutics[J].Central European Journal of Biology,2007,2 (1):1-33.
10BOMAN H G.Peptide antibiotics and their role in innate immunity[J].Annu Rev Immunol,1995,13:61-92.
6HOSE N,LAROUR G, LE DIGUERHER G, et al. Risk factorsfor porcine post-weaning multisystemic wasting syndrome ( PMWS)in 149 French farrow-to-finish herds [J]. Prev Vet Med,2003 ,61(3) : 209-225.
7LC3PEZ-S0RIA S, SEGALS J, ROSE N, et al. An exploratorystudy on risk factors for postweaning multisystemic wasting syn-drome (PMWS) in Spain [J]. Prev Vet Med, 2005,69(1-2):97-107.
8ROSE N, EVENO E,GRASLAND B, et al. Individual risk fac-tors for post-weaning multisystemic wasting syndrome ( PMWS) inpigs: a hierarchical Bayesian survival analysis [J]. Prev VetMed, 2009, 90(34) : 168-179.
9HOLTKAMP D J, YESKE P E, POLSON D D, et al. A prospec-tive study evaluating duration of swine breeding herd PRRS virus-free status and its relationship with measured risk [J]. Prev VetMed, 2010,96(34) : 186-193.
10DERALD J H,LIN H, WANG C,et al. Identifying questions inthe American Association of Swine Veterinarian , s PRRS risk as-sessment survey that are important for retrospectively classifyingswine herds according to whether they reported clinical PRRS out-breaks in the previous 3 years[J]. Prev Vet Med, 2012,106 :42-52.
